Full Name
Abigail Albright
Job Title
Product Evangelist
Company
Maxwell Health
Speaker Bio
Vinay Gidwaney is Chief Product Officer and Co-Founder at Maxwell Health. Having served as the CPO and Co-Founder at the mobile fitness app DailyFeats, one of Maxwell’s wellness brand affiliates, Vinay has a proven track record in creating online experiences that build positive change.
Prior to joining DailyFeats and Maxwell, Vinay was the Chief Technology Officer and Co-Founder of Control-F1, starting the company shortly after high school. An industry leader in Support Automation, Control-F1 served more than 100 customers worldwide, had 50 employees, and raised $13 million in venture capital. In December of 2005, Control-F1 was acquired by CA Technologies, one of the world’s largest software companies, exceeding $4 billion in sales.
Vinay was also Director and a founding investor of Neurosilicon, a life science company focused on advancing healthcare research through enabling rapid, non-invasive, targeted depolarization of excitable cells using the company’s novel photoconductive stimulation technology. In early 2008, Gidwaney was invited to be a visiting researcher in the Synthetic Neurobiology Group at MIT Media Lab. Under the leadership of Dr. Ed Boyden, Vinay helped to invent novel devices to control neuronal circuits for the treatment of neurological disorders.
Vinay is a 2002 winner of the prestigious MIT Technology Review Magazine Top 100 Innovators Under 35 award. He has previously been featured as a speaker at BenefitsPRO Broker Expo, Startup Health’s Health Transformers, LIMRA’s Enrollment Technology Conference, TEDMED, and on Bloomberg Radio and TV.
Prior to joining DailyFeats and Maxwell, Vinay was the Chief Technology Officer and Co-Founder of Control-F1, starting the company shortly after high school. An industry leader in Support Automation, Control-F1 served more than 100 customers worldwide, had 50 employees, and raised $13 million in venture capital. In December of 2005, Control-F1 was acquired by CA Technologies, one of the world’s largest software companies, exceeding $4 billion in sales.
Vinay was also Director and a founding investor of Neurosilicon, a life science company focused on advancing healthcare research through enabling rapid, non-invasive, targeted depolarization of excitable cells using the company’s novel photoconductive stimulation technology. In early 2008, Gidwaney was invited to be a visiting researcher in the Synthetic Neurobiology Group at MIT Media Lab. Under the leadership of Dr. Ed Boyden, Vinay helped to invent novel devices to control neuronal circuits for the treatment of neurological disorders.
Vinay is a 2002 winner of the prestigious MIT Technology Review Magazine Top 100 Innovators Under 35 award. He has previously been featured as a speaker at BenefitsPRO Broker Expo, Startup Health’s Health Transformers, LIMRA’s Enrollment Technology Conference, TEDMED, and on Bloomberg Radio and TV.
Speaking At
